Clinical Trial Update: A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Rekovelle (follitropin delta) with GONAL-F (follitropin alfa) for ovarian response using conventional dosing during controlled ovarian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonal-F (follitropin alfa)
• Rekovelle (follitropin delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2025-04-02